MEDICARE PART B CLINICAL LABORATORY FEE SCHEDULE CUTS mandated by PAMA continue to bite deeply. A new government report shows that during fiscal 2020, the Medicare program spent 15.9% less for lab tests, when COVID-19 test payments are excluded. The federal Department of Health and Human Services Office of Inspector General (OIG) recently released a […]
- Regulatory Update
Non-COVID Part B Lab Spend Declined by 15.9% in 2020
OIG says 2020 Medicare Part B CLFS spending for non-COVID tests was $6.5 billion, lowest since 2016
- By Robert Michel
- > From the Volume XXIX, No. 2 - January 31, 2022 Issue
